South America Urinalysis Market

Market Introduction

SAM region for the estimating the market for the Urinalysis consist of countries such as Brazil, Argentina, and rest of SAM. The region held smallest portion of the market in the overall analysis. The market is likely to propel in the forecasted period owing to the recent technological developments which have made a direct impact on the economy of Brazil that has advanced to a large extent. Increasing disposable income in the South American countries, rising number of surgical procedures, increasing medical tourism industry for surgeries, and increasing number of urinalysis procedures are expected to be the key factors for the growth of SAM urinalysis market in the coming years. However, economic instability in SAM is likely to pose a challenge during the forecast period.

The COVID-19 pandemic had a sudden, dramatic impact on healthcare in SCAM. Hospitals and clinics had to postpone the prescheduled appointments. People hospitalized with COVID-19 were at significant risk of acute kidney damage (AKI), which results in serious illness, dialysis, and even death. Recovered COVID-19 patients with AKI or acute respiratory failure (ARF) were advised to have regular renal examinations due to the risk of developing chronic kidney disease. Women with UTI symptoms such as dysuria, worsening frequency or urgency, and gross hematuria were initially treated by remote communication. COVID-19 had also impacted the regulatory environment and practices as governments and healthcare providers faced unprecedented challenges.            

Market Overview and Dynamics

The urinalysis market in SAM is expected to grow from US$ 368.45 million in 2021 to US$ 501.91 million by 2028; it is estimated to grow at a CAGR of 4.5% from 2021 to 2028. Major countries contributing to the market's growth include Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia. The countries offer significant growth opportunities for the growth of the market. Countries are improving their health infrastructures by allowing new entrants to enter the business. Therefore, it is expected that the demand for urinalysis will increase. In addition, countries in the region are investing and interested in improving their health care and focusing on primary and advanced care. Therefore, it is expected that the number of health facilities in these countries will increase. Therefore, the urinalysis market is expected to offer significant growth opportunities in the SAM region during the forecast period due to the factors mentioned above.  

Key Market Segments

SAM urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the SAM urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The SAM urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the SAM urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The SAM urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the SAM urinalysis market is segmented into Brazil, Argentina, and rest of SAM. Brazil held the largest market share in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the urinalysis market in SAM are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; and Sysmex Corporation.         

Reasons to buy report

• To understand the SAM urinalysis market landscape and identify market segments that are most likely to guarantee a strong return.
• Stay ahead of the race by comprehending the ever-changing competitive landscape for SAM urinalysis market.
• Efficiently plan M&A and partnership deals in SAM urinalysis market by identifying market segments with the most promising probable sales.
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form SAM urinalysis market.
• Obtain market revenue forecast for market by various segments from 2021-2028 in SAM region.

SAM Urinalysis Market Segmentation

SAM Urinalysis Market - By Product

• Consumables
• Instruments

SAM Urinalysis Market - By Test Type

• Pregnancy and Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

SAM Urinalysis Market - By Application

• Disease Screening
• Pregnancy and Fertility

SAM Urinalysis Market - By End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Research Laboratories and Institutes

SAM Urinalysis Market - By Country

• Brazil
• Argentina
• Rest of SAM

SAM Urinalysis Market - Company Profiles

• Abbott    
• ACON Laboratories, Inc.             
• ARKRAY, Inc.     
• Beckman Coulter, Inc.     
• Bio-Rad Laboratories Inc.            
• Cardinal Health Inc         
• F. Hoffmann-La Roche Ltd.          
• Siemens Healthineers AG           
• Sysmex Corporation

South America Urinalysis Market Strategic Insights

South America UrinalysisMarket Report Highlights

South America Urinalysis Market Country and Regional Insights